Premium
Effects of recombinant human thrombopoietin on megakaryocyte colony formation and megakaryocyte ploidy by human CD34 + cells in a serum‐free system
Author(s) -
Angchaisuksiri Pantep,
Carlson Patricia,
Dessypris Emmanuel
Publication year - 1996
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.1996.4761013.x
Subject(s) - megakaryocyte , thrombopoietin , stem cell factor , erythropoietin , haematopoiesis , thrombopoiesis , interleukin 3 , biology , recombinant dna , cd34 , interleukin 11 , progenitor cell , stem cell , microbiology and biotechnology , immunology , cytokine , interleukin , endocrinology , biochemistry , t cell , immune system , antigen presenting cell , gene
In serum‐free cultures of human CD34 cells, recombinant human thrombopoietin (TPO) induced megakaryocyte colony formation in a dose‐dependent fashion that was further enhanced by the presence of interleukin‐3 (IL‐3) and stem cell factor (SCF), but not by IL‐6, IL‐11 or erythropoietin. TPO gave rise to much smaller colonies and at an earlier time than IL‐3, indicating that TPO affects predominantly more mature megakaryocytic progenitors. In liquid cultures, TPO increased the percentage and the absolute number of ≥8N megakaryocytes, but it did not shift their modal ploidy from 2N. TPO‐induced endomitosis was totally inhibited by the presence of, or previous exposure of cells to, IL‐3 and/or SCF. The mechanism by which TPO overcomes in vivo the negative effects of IL‐3 and SCF on megakaryocyte ploidy remains unknown.